• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Lisinopril-associated bullous pemphigoid in an elderly woman: a case report of a rare adverse drug reaction.老年女性患者应用赖诺普利后发生大疱性类天疱疮:一种罕见药物不良反应的病例报告。
Br J Clin Pharmacol. 2018 Nov;84(11):2678-2682. doi: 10.1111/bcp.13737. Epub 2018 Aug 29.
2
Can pemphigoid be provoked by lisinopril?赖诺普利会引发类天疱疮吗?
Br J Dermatol. 2006 Oct;155(4):854-5. doi: 10.1111/j.1365-2133.2006.07453.x.
3
Oral bullous eruption after taking lisinopril--case report and literature review.服用赖诺普利后出现口腔大疱性皮疹——病例报告及文献复习。
Wien Klin Wochenschr. 2013 Jul;125(13-14):408-11. doi: 10.1007/s00508-013-0382-7. Epub 2013 Jun 21.
4
Bullous Pemphigoid Masquerading as Erythema Annulare Centrifugum.伪装成离心性环状红斑的大疱性类天疱疮
Acta Dermatovenerol Croat. 2017 Oct;25(3):255-256.
5
Bullous pemphigoid associated with captopril.与卡托普利相关的大疱性类天疱疮。
DICP. 1989 Jan;23(1):63. doi: 10.1177/106002808902300115.
6
Case Report: A Rare Case of Pembrolizumab-Induced Bullous Pemphigoid.病例报告:一例罕见的帕博利珠单抗诱导的大疱性类天疱疮。
Front Immunol. 2021 Sep 14;12:731774. doi: 10.3389/fimmu.2021.731774. eCollection 2021.
7
Clindamycin-induced Maculopapular Exanthema with Preferential Involvement of Striae Distensae: A Koebner phenomenon?克林霉素诱发的斑丘疹伴膨胀纹优先受累:同形反应现象?
Acta Dermatovenerol Croat. 2018 Apr;26(1):61-63.
8
Double-blind comparison of losartan, lisinopril, and metolazone in elderly hypertensive patients with previous angiotensin-converting enzyme inhibitor-induced cough.氯沙坦、赖诺普利和美托拉宗在曾因血管紧张素转换酶抑制剂引发咳嗽的老年高血压患者中的双盲比较
J Clin Pharmacol. 1997 Mar;37(3):253-7. doi: 10.1002/j.1552-4604.1997.tb04788.x.
9
Drug-aggravated Bullous Pemphigoid in a 47-year-old Asian Woman - A Case Report.47 岁亚裔女性药物诱发大疱性类天疱疮病例报告。
Curr Drug Saf. 2023;18(3):379-382. doi: 10.2174/1574886317666220518091554.
10
Ciprofloxacin as a Trigger for Bullous Pemphigoid: The Second Case in the Literature.环丙沙星引发大疱性类天疱疮:文献中的第二例病例
Am J Ther. 2016 Sep-Oct;23(5):e1202-4. doi: 10.1097/MJT.0000000000000283.

引用本文的文献

1
Lymphocyte Transformation Tests and Patch Tests to Identify Drugs Potentially Associated With Bullous Pemphigoid Development.淋巴细胞转化试验和斑贴试验以鉴定可能与大疱性类天疱疮发生相关的药物。
Int J Dermatol. 2025 Sep;64(9):1636-1643. doi: 10.1111/ijd.17849. Epub 2025 May 15.
2
Associated factors related to production of autoantibodies and dermo-epidermal separation in bullous pemphigoid.大疱性类天疱疮中与自身抗体产生及皮肤表皮分离相关的因素。
Arch Dermatol Res. 2025 Jan 24;317(1):303. doi: 10.1007/s00403-024-03760-0.
3
From Molecular Insights to Clinical Perspectives in Drug-Associated Bullous Pemphigoid.从药物相关性大疱性表皮松解症的分子见解到临床观点。
Int J Mol Sci. 2023 Nov 26;24(23):16786. doi: 10.3390/ijms242316786.
4
The Renin-Angiotensin System: The Challenge behind Autoimmune Dermatological Diseases.肾素-血管紧张素系统:自身免疫性皮肤病背后的挑战
Diagnostics (Basel). 2023 Nov 7;13(22):3398. doi: 10.3390/diagnostics13223398.
5
Risk heterogeneity of bullous pemphigoid among dipeptidyl peptidase-4 inhibitors: A population-based cohort study using Japanese Latter-Stage Elderly Healthcare Database.二肽基肽酶-4 抑制剂致大疱性类天疱疮的风险异质性:一项基于日本后期高龄者医疗数据库的人群队列研究。
J Diabetes Investig. 2023 Jun;14(6):756-766. doi: 10.1111/jdi.14004. Epub 2023 Mar 10.
6
Levofloxacin-Associated Bullous Pemphigoid in a Hemodialysis Patient After Kidney Transplant Failure.左氧氟沙星相关性大疱性类天疱疮在肾移植失败后血液透析患者中的发生。
Am J Case Rep. 2022 Dec 29;23:e938476. doi: 10.12659/AJCR.938476.
7
New-Onset Bullous Pemphigoid in a COVID-19 Patient.一名新冠肺炎患者新发大疱性类天疱疮
Case Rep Dermatol Med. 2021 Jun 7;2021:5575111. doi: 10.1155/2021/5575111. eCollection 2021.

本文引用的文献

1
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.2018 年 IUPHAR/BPS 药理学指南:更新和扩展,以包含新的免疫药理学指南。
Nucleic Acids Res. 2018 Jan 4;46(D1):D1091-D1106. doi: 10.1093/nar/gkx1121.
2
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors.《药理学 2017/18 简明指南:G 蛋白偶联受体》
Br J Pharmacol. 2017 Dec;174 Suppl 1(Suppl Suppl 1):S17-S129. doi: 10.1111/bph.13878.
3
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes.《药理学简明指南 2017/18:酶》
Br J Pharmacol. 2017 Dec;174 Suppl 1(Suppl Suppl 1):S272-S359. doi: 10.1111/bph.13877.
4
Pemphigus foliaceus as a differential diagnosis in vesicobullous lesions.落叶型天疱疮作为水疱大疱性皮损的鉴别诊断。
Einstein (Sao Paulo). 2017 Apr-Jun;15(2):220-222. doi: 10.1590/S1679-45082017RC3828.
5
Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment.大疱性类天疱疮:诊断、相关因素及治疗综述
Am J Clin Dermatol. 2017 Aug;18(4):513-528. doi: 10.1007/s40257-017-0264-2.
6
Drug-induced pemphigoid: a review of the literature.药物性类天疱疮:文献综述
J Eur Acad Dermatol Venereol. 2014 Sep;28(9):1133-40. doi: 10.1111/jdv.12366. Epub 2014 Jan 10.
7
Bullous pemphigoid: etiology, pathogenesis, and inducing factors: facts and controversies.大疱性类天疱疮:病因、发病机制和诱发因素:事实与争议。
Clin Dermatol. 2013 Jul-Aug;31(4):391-399. doi: 10.1016/j.clindermatol.2013.01.006.
8
Drug-induced pemphigus.药物诱导性天疱疮。
Clin Dermatol. 2011 Jul-Aug;29(4):455-7. doi: 10.1016/j.clindermatol.2011.01.016.
9
Diagnosis and clinical features of pemphigus foliaceus.寻常型天疱疮的诊断与临床特征。
Dermatol Clin. 2011 Jul;29(3):405-12, viii. doi: 10.1016/j.det.2011.03.012.
10
Medication history of a series of patients with bullous pemphigoid from northern Greece - observations and discussion.希腊北部一系列大疱性类天疱疮患者的用药史——观察与讨论
Int J Dermatol. 2009 Feb;48(2):132-5. doi: 10.1111/j.1365-4632.2009.03839.x.

老年女性患者应用赖诺普利后发生大疱性类天疱疮:一种罕见药物不良反应的病例报告。

Lisinopril-associated bullous pemphigoid in an elderly woman: a case report of a rare adverse drug reaction.

机构信息

Faculty of Medicine, American University of Beirut, Beirut, Lebanon.

Department of Family Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

出版信息

Br J Clin Pharmacol. 2018 Nov;84(11):2678-2682. doi: 10.1111/bcp.13737. Epub 2018 Aug 29.

DOI:10.1111/bcp.13737
PMID:30155951
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6177705/
Abstract

An 87-year-old woman with a long-standing history of hypertension, hypothyroidism and diabetes presented to us with scaly and pruritic vesicles of an erythematous base and crusted surface of 2-month duration. They first appeared on her abdomen and gradually spread to her lower back, thighs, before spreading to her upper and lower limbs. Her lesions were non-painful, aggravated by sun exposure only, and sparing mucous membranes. Nikolsky sign was positive with no discernible fluid-filled bullae. History was remarkable only for a doubling of her Lisinopril dosage 2 months prior to the appearance of her lesions, with no other potential environmental and/or drug triggers recognizable on history taking. In light of the appearance of her lesions after her Lisinopril dose escalation, in the absence of any other discernible triggers, an adverse drug reaction (ADR) was entertained, yielding a corresponding Naranjo ADR probability score of 7. Particularly, drug-induced pemphigus foliaceus was initially suspected given her clinical presentation and the morphology and distribution of her lesions. However, her skin biopsy altered our diagnosis to drug-induced bullous pemphigoid (BP) instead, making this the second case reported to date on Lisinopril-induced BP, and the first to report a dose-response variant of this adverse reaction.

摘要

一位 87 岁的女性,有长期高血压、甲状腺功能减退和糖尿病病史,因红斑基础上有鳞屑和瘙痒性水疱,病程 2 个月,前来就诊。这些水疱最初出现在她的腹部,逐渐蔓延到她的下背部和大腿,然后扩散到她的上下肢。她的皮损无痛,仅在暴露于阳光下时加重,不累及黏膜。尼氏征阳性,未见明显充满液体的大疱。病史中唯一显著的是在皮损出现前 2 个月她的赖诺普利剂量增加了一倍,但在病史询问中没有发现其他潜在的环境和/或药物诱因。鉴于她在赖诺普利剂量增加后出现皮损,且没有其他明显的诱因,考虑为药物不良反应(ADR),相应的 Naranjo ADR 概率评分为 7。特别是,鉴于她的临床表现以及皮损的形态和分布,最初怀疑为药物诱导性类天疱疮。然而,她的皮肤活检改变了我们的诊断,提示为药物诱导性大疱性类天疱疮(BP),这是迄今为止第二例赖诺普利诱导 BP 的报告,也是首例报告这种不良反应的剂量反应变异型。